Craft

Julphar

Revenue

د.إ1.1 B

FY, 2025

Julphar Summary

Company Summary

Overview
Julphar (also known as Gulf Pharmaceutical Industries) is a company that produces medicines, vaccines, and consumer healthcare products. Its medicines target major therapeutic segments including the gastrointestinal tract (GIT), respiratory, pain management, wounds and scars, anti-infectives, anemia, gynecology, dermatology, erectile dysfunction, and cardiology.
Type
Public
Status
Active
Founded
1980
HQ
Ras Al-Khaimah, AE | view all locations
Website
http://www.julphar.net/
Cybersecurity rating
ESG rating
30-39 out of 100|View all ESG data
Sectors

Key People

  • Saqer Humaid Al Qasimi

    Saqer Humaid Al Qasimi, Chairman of the Board

    • Gopa Kumar

      Gopa Kumar, Chief Human Resources Officer

      • Essam Farouk

        Essam Farouk, Chief Executive Officer

        • Yousef Ali Mohammed

          Yousef Ali Mohammed, Vice-Chairman of the Board

          LocationsView all

          1 location detected

          • Ras Al-Khaimah, Ras al Khaimah HQ

            United Arab Emirates

          Julphar Financials

          Summary Financials

          Revenue (FY, 2025)
          د.إ1.1B
          Gross profit (FY, 2025)
          د.إ481.2M
          Net income (FY, 2025)
          د.إ155.1M
          Cash (FY, 2025)
          د.إ229.6M
          EBIT (FY, 2025)
          د.إ184.1M

          Footer menu